Correlation Between Strategic Allocation: and Health Biotchnology

Can any of the company-specific risk be diversified away by investing in both Strategic Allocation: and Health Biotchnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Strategic Allocation: and Health Biotchnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Strategic Allocation Moderate and Health Biotchnology Portfolio, you can compare the effects of market volatilities on Strategic Allocation: and Health Biotchnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Strategic Allocation: with a short position of Health Biotchnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Strategic Allocation: and Health Biotchnology.

Diversification Opportunities for Strategic Allocation: and Health Biotchnology

0.49

Correlation Coefficient

Strategic Allocation:  Health Biotchnology

Very weak diversification

The 3 months correlation between Strategic and Health is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Strategic Allocation Moderate and Health Biotchnology Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Health Biotchnology and Strategic Allocation: is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Strategic Allocation Moderate are associated (or correlated) with Health Biotchnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Health Biotchnology has no effect on the direction of Strategic Allocation: i.e., Strategic Allocation: and Health Biotchnology go up and down completely randomly.

Pair Corralation between Strategic Allocation: and Health Biotchnology

Assuming the 90 days horizon Strategic Allocation Moderate is expected to under-perform the Health Biotchnology. But the mutual fund apears to be less risky and, when comparing its historical volatility, Strategic Allocation Moderate is 1.31 times less risky than Health Biotchnology. The mutual fund trades about -0.01 of its potential returns per unit of risk. The Health Biotchnology Portfolio is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,877  in Health Biotchnology Portfolio on December 30, 2024 and sell it today you would earn a total of  57.00  from holding Health Biotchnology Portfolio or generate 3.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Strategic Allocation Moderate  vs.  Health Biotchnology Portfolio

Strategic Allocation:

Risk-Adjusted Performance

Very Weak

Over the last 90 days Strategic Allocation Moderate has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Strategic Allocation: is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Health Biotchnology Portfolio are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Health Biotchnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Strategic Allocation: and Health Biotchnology

The main advantage of trading using opposite Strategic Allocation: and Health Biotchnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Strategic Allocation: position performs unexpectedly, Health Biotchnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will offset losses from the drop in Health Biotchnology's long position.

The idea behind Strategic Allocation Moderate and Health Biotchnology Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.